Evaluation of PTEN loss and PIK3CA mutations and their correlation with efficacy of trastuzumab treatment in HER2-positive metastatic breast cancer: A retrospective study (KBC-SG 1001)
about
Evaluation of AKT phosphorylation and PTEN loss and their correlation with the resistance of rituximab in DLBCL.Anticancer effect of deoxypodophyllotoxin induces apoptosis of human prostate cancer cells.Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab.
P2860
Evaluation of PTEN loss and PIK3CA mutations and their correlation with efficacy of trastuzumab treatment in HER2-positive metastatic breast cancer: A retrospective study (KBC-SG 1001)
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 August 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evaluation of PTEN loss and PI ...... rospective study (KBC-SG 1001)
@en
Evaluation of PTEN loss and PI ...... cancer: A retrospective study
@nl
type
label
Evaluation of PTEN loss and PI ...... rospective study (KBC-SG 1001)
@en
Evaluation of PTEN loss and PI ...... cancer: A retrospective study
@nl
prefLabel
Evaluation of PTEN loss and PI ...... rospective study (KBC-SG 1001)
@en
Evaluation of PTEN loss and PI ...... cancer: A retrospective study
@nl
P2093
P2860
P356
P1476
Evaluation of PTEN loss and PI ...... rospective study (KBC-SG 1001)
@en
P2093
Kazuo Tamura
Keisei Anan
Nobuyuki Arima
Reiki Nishimura
Satoshi Toyoshima
Shoshu Mitsuyama
Yasuyo Ohi
P2860
P356
10.3892/MCO.2012.10
P577
2012-08-09T00:00:00Z